LUCAN PHARMA LTD
Executive Summary
LUCAN PHARMA LTD is in an embryonic stage within the pharmaceutical manufacturing and wholesale sector, currently dormant but positioned to enter a complex and capital-intensive industry. Its strategic advantage lies in the potential for vertical integration and agile governance, though significant operational activation and capital investment are needed to realize growth. The company must prioritize regulatory compliance, market entry strategies, and capital acquisition to overcome inherent risks and competitive pressures in establishing a foothold.
View Full Analysis Report →- Legal registered address
- 41 Provis Wharf Provis Wharf Aylesbury England HP20 1AQ Copied!
Latest financial results as of 2 August 2025- Shareholders funds
- £100
View full financial accounts- Shareholders funds
- £100
- Company number
- 14379572 Copied!
Accounts
Latest annual accounts were to 30 September 2024
Next annual accounts are due by 30 June 2026
Company financial year end is on 30 September 2025
Confirmation statement
Latest confirmation statement statement dated 17 September 2024
Next statement due by 1 October 2025
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
21200 - Manufacture of pharmaceutical preparations
46460 - Wholesale of pharmaceutical goods
Latest company documents
| Date | Description |
|---|---|
| 06/06/256 June 2025 New | Accounts for a dormant company made up to 2024-09-30 |
| 14/04/2514 April 2025 | Secretary's details changed for Daniel Peter Luc Van Der Walt on 2025-02-01 |
| 14/04/2514 April 2025 | Registered office address changed from 29 Old Union Way Thame Oxfordshire OX9 2DF England to 41 Provis Wharf Provis Wharf Aylesbury HP20 1AQ on 2025-04-14 |
| 14/04/2514 April 2025 | Director's details changed for Daniel Peter Luc Van Der Walt on 2025-02-01 |
| 30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company